Where do new medicines start? They start in the lab, where scientists study the biological mechanisms that contribute to good health or, when they go awry, cause disease. Beaker highlights interesting science, Sanford-Burnham Medical Research Institute and our supporters.
Beaker's Latest Posts
Pedal the Cause announced the cancer research projects that will be funded from last year's cycling fundraiser. The projects are geared toward the steps neede to take discoveries from "bench-to-beside"
Karen Hooper (right), executive vice president of the National MS Society's Pacific South Coast Chapter, presenting Dr. Barbara Ranscht (left) with their chapter's Researcher of the Year Award.
Multiple sclerosis is the most common neurological disease in young adults, usually striking between the ages of 20 and 40 years.
Sanford-Burnham will host a cancer research tweet chat on March 31 at 8 p.m. ET/ 5 p.m. PT.
New research expands the number of molecular targets to treat melanoma, the most deadly type of skin cancer.
Log in to leave a comment